This study is to evaluate the safety, efficacy, and pharmacokinetics of E7080 when orally
administered once daily (QD) in subjects with advanced thyroid cancer.
Drug: E7080 capsule
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT01728623
Ages eligible for Study
20 Years and older
Genders eligible for Study
Accepts Healthy Volunteers
All locations for NCT01728623
Kashiwa, Chiba, Japan
Kobe, Hyogo, Japan
Koto-ward, Tokyo, Japan
View full eligibility
Tris trial is registered with FDA with number: NCT01728623. The sponsor of the trial is Eisai Co., Ltd. and it is looking for 37 volunteers for the current phase. Official trial title: A Phase 2 Study of E7080 in Subjects With Advanced Thyroid Cancer
Thank you for applying!
We'll contact you soon with more information.
FindMeCure is constantly improving its search. Take part in it and help millions by filling our patients' survey!